How do I submit a preliminary application under Article 63 MiCAR to the FMA in Liechtenstein?

Request an informal preliminary discussion by emailing the FMA's dedicated fintech contact at casp@fma-li.li . Include a brief project description and the licence type sought. Following the Regulatory Laboratory pre‑application meeting and the FMA's written opinion, prepare the full document pack and submit the formal application through the FMA's e‑Service portal.

What documents are required for an FMA pre‑application and Regulatory Laboratory meeting?

Core documents include a signed cover letter and executive summary, corporate formation documents, a three‑year business plan with financial projections, organisational charts and CVs for all key persons, board‑approved AML/CFT and IT resilience policies, auditor appointment letters, proof of minimum capital, outsourcing contracts and sample client agreements. See the full required documents table above for detailed guidance on format and issuer.

How long does the FMA pre‑application review and Regulatory Laboratory assessment take?

The FMA must assess completeness of a formal application within 25 working days under Article 63 of Regulation (EU) 2023/1114 (MiCAR). Once the application is deemed complete, Liechtenstein law provides the FMA up to six months to reach a final decision. The Regulatory Laboratory opinion is typically issued two to four weeks after the pre‑application meeting. Practical end‑to‑end timelines from first FMA contact to final decision range from four to nine months, depending on complexity and RFI responsiveness.

Can a non‑EEA firm use Liechtenstein's pre‑application process to passport services into the EEA?

Liechtenstein implements MiCAR as an EEA member and its authorisations enable passporting into all 30 EEA states. However, the non‑EEA firm must establish a Liechtenstein entity or branch with genuine local substance, satisfy fit‑and‑proper requirements and comply with the host‑state notification procedures that apply to the specific licence type. Applicants should map target markets and the applicable passporting regime before the pre‑application meeting.

Is the Regulatory Laboratory opinion binding on the FMA?

The Regulatory Laboratory opinion is the FMA's documented preliminary position and strongly guides the subsequent formal review. It is not a substitute for a final licensing decision and does not create a legal entitlement to authorisation. In practice, however, the opinion materially shapes the application scope and identifies the specific requirements the applicant must fulfil, disregarding its recommendations will almost certainly cause delays.

What happens if I miss the completeness deadline or fail to respond to an RFI?

The FMA may pause the substantive review for as long as the deficiency remains unresolved. Late or inadequate responses to RFIs risk a finding that the application is incomplete, which can restart the 25‑working‑day completeness clock. In persistent cases, the FMA may refuse the application. The recommended approach is to respond to each RFI within the timeframe specified, use the Regulatory Laboratory opinion to prioritise critical fixes, and notify the FMA promptly if additional time is needed.

How to Apply: FMA Pre‑application (regulatory Laboratory) Process for Digital‑asset & Payments Firms, Liechtenstein (2026)

Understanding how to apply for an FMA pre‑application in Liechtenstein is now one of the most consequential early steps for any digital‑asset or payments firm planning to operate in the European Economic Area. The Finanzmarktaufsicht (FMA), Liechtenstein’s financial regulator, runs a dedicated Regulatory Laboratory that allows prospective applicants to present their business model, governance structure and compliance framework before submitting a formal licence application under Article 63 of Regulation (EU) 2023/1114 (the Markets in Crypto‑Assets Regulation, or MiCAR). This pre‑application meeting produces a written opinion that materially shapes the scope, document requirements and timeline of the subsequent authorisation process.

With MiCAR and Liechtenstein’s Token and Trusted Technology Service Provider Act (TVTG) now fully aligned, the Regulatory Laboratory has become the primary entry point for crypto‑asset service providers (CASPs), payment institutions, e‑money institutions (EMIs) and token issuers seeking a Liechtenstein licence in 2026.

Overview of the FMA Pre‑Application Process and Who It Applies To

The FMA pre‑application process is a structured, voluntary dialogue between an applicant and the FMA’s Regulatory Laboratory. Its purpose is twofold: first, to give the FMA early visibility of the applicant’s business model, risk profile and governance arrangements; second, to give the applicant a documented preliminary assessment, the Regulatory Laboratory opinion, that identifies gaps, confirms the applicable regulatory regime and narrows the scope of the formal application.

The process is available to firms seeking authorisation under several frameworks administered by the FMA, including:

CASP authorisation under MiCAR (Regulation (EU) 2023/1114)
Token issuances, asset‑referenced tokens (ARTs) and e‑money tokens (EMTs) under MiCAR
Payment institution licences under FMA Guidance 2019/8
E‑money institution licences under FMA Guidance 2018/18
TVTG registrations for trustworthy technology service providers

Because Liechtenstein is a member of the EEA, an authorisation granted by the FMA enables passporting of services into all 30 EEA member states, a critical advantage for non‑EEA firms seeking a single European gateway. Industry observers expect the Regulatory Laboratory route to be the default first contact for the majority of CASP and payment‑firm applicants in 2026. Eligibility requirements and the foreign‑applicant checklist are discussed in detail below.

Eligibility and Prerequisites for the FMA Pre‑Application

Which Licences Use Article 63 / Regulatory Laboratory

The Article 63 MiCAR pre‑application pathway applies primarily to CASP applications and token issuances (ARTs and EMTs). Payment institutions and EMIs follow a parallel but closely analogous pre‑application procedure described in FMA Guidance 2019/8 (payment institutions) and FMA Guidance 2018/18 (e‑money institutions). In practice, the FMA uses the Regulatory Laboratory as the initial contact point for all of these licence types, even though the statutory basis differs slightly between MiCAR‑regulated activities and payment‑services activities.

At a high level, applicants must demonstrate the following before the FMA will engage substantively in a pre‑application meeting:

A clearly defined business model specifying the crypto‑asset services or payment services to be offered
An identified corporate structure, whether a newly incorporated Liechtenstein entity, a branch or a subsidiary of a foreign parent
Preliminary identification of key persons (directors, money‑laundering reporting officer (MLRO), CEO, CTO) and their fitness and propriety
An outline of governance, AML/CFT and IT resilience arrangements
Evidence, or a credible plan, for meeting statutory minimum capital requirements applicable to the relevant licence type

Foreign Applicant Checklist

Non‑EEA firms may use the Liechtenstein pre‑application process as a route to EEA market access. Key prerequisites for foreign applicants include:

Local presence. The FMA expects the licensed entity to maintain effective decision‑making, compliance and risk management in Liechtenstein, whether through a locally incorporated company or a registered branch. Purely nominee arrangements without genuine substance are unlikely to satisfy the FMA.
Fit and proper assessment. All key persons must pass the FMA’s fit‑and‑proper review. Non‑resident directors are permissible in some structures, but at least one locally‑resident director is strongly recommended.
EEA passporting considerations. Once authorised, the firm may passport services into the EEA. However, passporting mechanics and host‑state notification requirements differ between the CASP licence (MiCAR), payment institution and EMI regimes. Applicants should map their target markets before the pre‑application meeting, as this affects the application scope the FMA reviews.

Step‑by‑Step: How to Apply for an FMA Pre‑Application in Liechtenstein

The following numbered steps walk through the complete procedure, from internal readiness through to the FMA’s completeness check after formal submission. The timeline table at the end of this section summarises who does what, and how long each phase typically takes.

Step 1, Conduct Internal Scoping and Prepare the Document Pack

Assemble a project team comprising at minimum: a senior executive sponsor (CEO or founder), the designated MLRO, legal counsel (in‑house or external), and the CTO or head of IT. Define the regulatory perimeter, which crypto‑asset services or payment services will be offered, in which EEA markets, and under which licence type. Prepare a one‑page executive summary and begin drafting the business plan, governance policies and financial projections. This internal phase typically takes two to six weeks depending on organisational readiness.

Step 2, Request an Informal Preliminary Discussion with the FMA

Contact the FMA’s dedicated fintech unit by emailing casp@fma-li.li. Include a brief project description (two to three paragraphs), the licence type sought and a proposed meeting date range. The FMA’s informal preliminary discussions page confirms that this initial outreach is the expected entry point. Allow one to three weeks for the FMA to acknowledge the request and propose a meeting date. Attach the one‑page executive summary prepared in Step 1.

Step 3, Attend the Regulatory Laboratory Pre‑Application Meeting

The pre‑application meeting is typically conducted in person at the FMA’s offices in Vaduz (or via video conference) and lasts one to two hours. The applicant’s project team should attend, along with external legal counsel if engaged. The FMA will ask about the business model, target markets, governance arrangements, AML/CFT controls, IT architecture and capital plans.

A recommended meeting agenda is as follows:

Introductions and meeting objectives
Project summary and licence type sought
Product description and target EEA markets
Governance structure and key persons
AML/CFT and IT/operational resilience overview
Capital plan and business‑plan highlights
Open questions from the applicant and FMA
Next steps and indicative timetable

The FMA uses this meeting to form a preliminary view of the application’s completeness and to flag areas requiring additional work before formal submission.

Step 4, Receive the Regulatory Laboratory Opinion

Following the meeting, the FMA issues its Regulatory Laboratory opinion in writing, typically within two to four weeks. The opinion is not a formal approval, it is the FMA’s documented preliminary position on the applicant’s regulatory classification, the specific licence requirements that apply and any deficiencies that must be addressed before the formal application will be treated as complete. While not legally binding in the sense of a final decision, the opinion strongly guides the substantive review and, in practice, materially shapes both the scope and timeline of the formal application. Applicants who disregard the opinion’s recommendations risk significant delays or additional requests for information during the formal review.

Step 5, Finalise and Submit the Formal Application via the FMA e‑Service Portal

Using the Regulatory Laboratory opinion as a roadmap, finalise all required documents (see the documents table below). Submit the application through the FMA’s e‑Service portal together with all annexes and the cover letter. The submission itself takes one to two days once the document pack is complete, but internal preparation to address the Regulatory Laboratory’s recommendations often takes an additional two to eight weeks.

Step 6, FMA Completeness Check and Next Actions

Upon receipt of the application, the FMA conducts a completeness check. Under Article 63 of MiCAR, the FMA has 25 working days to assess whether the application is complete. If the FMA identifies deficiencies, it issues a request for information (RFI). Common RFI categories include: missing or insufficiently detailed AML/CFT policies; incomplete fit‑and‑proper documentation for key persons; and gaps in IT security evidence. Respond to each RFI promptly, unresolved RFIs pause the substantive review clock.

Step	Who Does It	Typical Duration
Internal scoping & document pack preparation	Applicant legal/compliance team (+ external counsel)	2–6 weeks
Request & schedule informal preliminary discussion with FMA (email to casp@fma-li.li)	Applicant (lead counsel / CEO)	1–3 weeks to schedule
Regulatory Laboratory meeting (pre‑application meeting)	Applicant team + FMA Regulatory Laboratory	1–2 hours (meeting)
FMA Regulatory Laboratory issues opinion	FMA (Regulatory Laboratory)	2–4 weeks (opinion issued in writing)
Submit Article 63 preliminary / full application via FMA e‑Service	Applicant	1–2 days (submission); internal prep often 2–8 weeks
FMA completeness check under Article 63	FMA	25 working days (statutory, Article 63 MiCAR)
FMA final decision on complete application	FMA	Up to 6 months from receipt of complete application (Liechtenstein implementing law)

Required Documents and FMA Checklist

The document pack presented at or before the Regulatory Laboratory pre‑application meeting, and ultimately submitted with the formal application, must be comprehensive. The FMA expects all materials in PDF format unless spreadsheets are specifically requested (e.g., financial projections). Documents not originally in English or German should be accompanied by certified translations. Corporate documents issued outside Liechtenstein may require apostille or consular legalisation depending on the country of origin.

The following FMA checklist covers the core documents required. Applicants should treat this as a minimum, the Regulatory Laboratory opinion may identify additional items specific to the business model.

Document	Notes (Issuer, Format, Key Content)
Cover letter & application summary	Applicant, PDF, signed; 1–2 page executive summary specifying scope of services and licence type sought.
Corporate documents (incorporation docs, articles, shareholders register)	Company registry / applicant, certified copy; translated to English or German; must disclose all beneficial owners.
Detailed business plan & financial projections (3 years)	Applicant (finance team / CFO), Excel + PDF; must include revenue model, capital plan, break‑even analysis and stress scenarios.
Organisational chart & CVs of key persons (directors, MLRO, CEO, CTO)	Applicant / individuals, signed CVs with fit‑and‑proper summaries and direct contact details.
Governance documents (AML/CFT policy, risk policy, IT/operational resilience, outsourcing policy)	Applicant, full board‑approved policies in PDF; evidence of board adoption date.
Technical / product whitepaper (token issuances, if applicable)	Applicant, whitepaper plus technical appendix; include smart contract audit reports where issued.
IT security & incident response evidence	Third‑party auditor / applicant, penetration test reports, security architecture diagrams; redacted where commercially necessary.
Audit & accounting arrangements	Auditor / applicant, engagement letters confirming auditor capacity and relevant experience; FMA may require prior approval of the appointed auditor.
Proof of minimum capital / bank reference	Bank / applicant, current bank statements and capital certificate demonstrating available funds and liquidity.
AML/KYC procedures & sanctions screening system description	Applicant, policies plus vendor attestations for any third‑party screening tools deployed.
Outsourcing contracts & service provider SLAs	Third parties, executed contracts for custody, cloud infrastructure and payment rails; specify data locations and sub‑processors.
Evidence of client onboarding flow & sample contracts	Applicant, sample client agreements, onboarding forms and KYC checklist.
Fee payment proof (where FMA filing fee applies)	Applicant, proof of payment; verify applicable fee directly with the FMA or the published FMA fee schedule.

Applicants planning to establish operations in Liechtenstein may also need to consider local hiring. For guidance on staffing requirements, see our article on how to hire non‑EEA workers in Liechtenstein.

Timeline and Key Deadlines for the FMA Pre‑Application Process

Two statutory deadlines anchor the timeline. First, under Article 63 of Regulation (EU) 2023/1114 (MiCAR), the FMA must assess whether an application is complete within 25 working days of receipt. Second, under Liechtenstein’s law implementing MiCAR, the FMA must reach a final decision within six months from receipt of the complete application. These are maximum periods; well‑prepared applications may proceed more quickly, while applications that trigger multiple RFI rounds will take longer in practice.

The table below sets out realistic timeframes for each phase, combining the statutory periods with practical experience.

Phase	What the FMA Does	Realistic Timeframe
Completeness check (Article 63 MiCAR)	FMA assesses whether the application is complete	25 working days (statutory)
Requests for additional information (RFI)	FMA issues RFIs to clarify deficiencies	2–6 weeks per round (depends on applicant response speed)
Substantive review after complete file received	FMA conducts technical, prudential and AML assessment	Up to 6 months from receipt of complete application (statutory)
Regulatory Laboratory opinion interval	Time for FMA to issue opinion after pre‑application meeting	Typically 2–4 weeks (varies by complexity)
Final licensing / approval decision	FMA decision (grant or refuse)	Practical projects: 4–9 months from first FMA contact (varies by complexity)

The most common source of delay is the RFI cycle. Each unanswered or inadequately answered RFI stops the clock on the substantive review. The practical effect is that an application described as “six months to decision” can stretch well beyond nine months if the applicant’s document pack was incomplete at the outset. The Regulatory Laboratory opinion, obtained before formal submission, is designed precisely to reduce this risk.

For broader context on MiCAR compliance deadlines affecting crypto businesses, see our dedicated overview.

Costs, Fees and Budget Considerations

Applicants should budget across two categories: official FMA regulatory fees and third‑party professional costs. The FMA publishes a fee schedule, but filing fees for pre‑applications and formal licence applications may vary by licence type and complexity. Applicants should confirm the applicable fee directly with the FMA before submission.

Item	Indicative Amount	Notes
FMA filing / application fee	Varies, check FMA fee schedule	Official regulatory fee; verify directly with FMA and attach receipt to application.
External legal fees (project management, application drafting)	Estimate: USD 25,000–100,000+ (project dependent)	Fees vary by scope, counsel and complexity; confirm per engagement.
External technical & security audits (penetration test, smart contract audit)	Estimate: USD 5,000–50,000+	Depends on product complexity and vendor; audits are often required before submission.
Auditor / accountant onboarding & initial audit readiness	Estimate: USD 5,000–25,000	Depends on firm and complexity of financial arrangements.
Minimum capital / regulated capital	Statutory minima depend on licence type	Payment institution, EMI and CASP regimes each specify different capital requirements, verify in the applicable legislation and FMA guidance.

All figures labelled “estimate” are indicative ranges and should be verified per engagement. Regulatory fees and statutory capital minima should be confirmed against the FMA’s current fee schedule and the relevant Liechtenstein legislation before budgeting.

What Changes in 2026: MiCAR, TVTG Convergence and the Regulatory Laboratory

The 2025–2026 period marks the point at which Liechtenstein’s domestic digital‑asset framework, anchored in the TVTG (the “Blockchain Act”), and the EU‑wide MiCAR framework have fully converged. Liechtenstein’s law implementing Regulation (EU) 2023/1114 transposes MiCAR into national law, creating a single regulatory track for crypto‑asset services that previously sat across two parallel regimes.

For applicants, the practical implications of this convergence are significant. The Regulatory Laboratory has assumed a central role in triaging applications, determining whether a business falls under the CASP regime, the TVTG registration regime, or both. The Regulatory Laboratory opinion now routinely specifies which regulatory requirements apply, what additional prudential measures the FMA expects, and whether the applicant needs separate audit approvals. The likely practical effect is that firms which skip the pre‑application meeting and proceed directly to a formal filing face materially longer review times and a higher risk of incomplete‑application findings during the Article 63 completeness check.

Early indications suggest that the FMA is using the Regulatory Laboratory process to streamline throughput and reduce the burden of serial RFI rounds, making the pre‑application stage, in effect, a mandatory tactical step for well‑advised applicants in 2026.

Common Pitfalls in the FMA Pre‑Application Process and How to Avoid Them

Incomplete AML/KYC policies. Applicants frequently present generic or template‑level AML/CFT policies that do not reflect the actual product, client base or jurisdictional risk profile. Mitigation: bring the designated MLRO to the Regulatory Laboratory meeting and present sample client onboarding flows with completed KYC checklists.
Missing technical audits for token or smart‑contract code. Token issuers who have not commissioned a smart contract audit before the pre‑application meeting risk being told to restart their preparation. Mitigation: schedule third‑party code audits at least six to eight weeks before the planned meeting date.
Underestimated capital or liquidity proofs. Some applicants arrive with outdated bank references or with insufficient capital relative to the licence type sought. Mitigation: confirm the applicable statutory capital minimum early, obtain current bank letters and present a clear capital plan in the business plan.
Weak CVs and fit‑and‑proper documentation for key persons. The FMA examines the fitness and propriety of directors, MLROs and senior management closely. Mitigation: prepare detailed CVs, professional references and confirmation of availability for FMA interviews before the meeting.
Rushed pre‑application meeting with an incomplete document pack. Presenting an incomplete or poorly organised pack wastes the Regulatory Laboratory session and delays the issuance of a usable opinion. Mitigation: use the documents table in this article as a checklist; prepare a one‑page executive summary; and circulate the agenda internally at least one week before the meeting.

Need Legal Advice?

This article was produced by Global Law Experts. For specialist advice on this topic, contact Josef Bergt at Bergt Law, a member of the Global Law Experts network.